# Vardenafil as add-on Therapy for Patients With Pulmonary Hypertension Treated With Inhaled Iloprost

> **NCT01649739** · PHASE4 · UNKNOWN · sponsor: **Rabin Medical Center** · enrollment: 20 (estimated)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** Levitra

## Key facts

- **NCT ID:** NCT01649739
- **Lead sponsor:** Rabin Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-09
- **Primary completion:** 2013-05
- **Final completion:** 2014-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2012-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01649739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01649739, "Vardenafil as add-on Therapy for Patients With Pulmonary Hypertension Treated With Inhaled Iloprost". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT01649739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
